Browse the evidence

Inhibition of ceramide biosynthesis improves glucose tolerance and insulin sensitivity in obese mice by restoring insulin signaling (Akt phosphorylation) in the liver and muscle.

Blocking ceramide production improves how the body handles sugar and insulin in obese mice, primarily by fixing signaling in the liver and muscles.

Elevated ceramide levels contribute to the expression of inflammatory adipokines MCP-1 and PAI-1, while TNF-alpha acts upstream of ceramide biosynthesis.

High ceramide levels drive inflammation markers like MCP-1 and PAI-1 in fat tissue, while TNF-alpha triggers ceramide production.

GLP-1 analogs exert pleiotropic effects on multiple tissues beyond glucose regulation, including neuroprotection, cardiac improvement, and metabolic reprogramming, mediated by cAMP/PKA/EPAC signaling pathways.

GLP-1 analogs (like semaglutide or liraglutide) are not just for blood sugar. They work by mimicking a natural hormone to signal your brain, heart, and gut. This leads to reduced appetite, better heart function, and potential protection for your brain and kidneys. Consistency is key because these benefits build over time through sustained receptor activation.

GLP-1 analogs protect pancreatic beta-cells from apoptosis and ER stress by promoting autophagy and metabolic reprogramming, thereby preserving beta-cell mass in Type 2 Diabetes.

GLP-1 analogs help keep your remaining insulin-producing cells alive by reducing stress and clearing out damaged cellular components (autophagy). This helps maintain your body's natural ability to produce insulin over time, which is crucial for long-term diabetes management.

Leptin is required to metabolically license activated effector T cells for glucose uptake and cytokine production, linking systemic nutritional status to immune function.

For optimal immune function, especially during stress or dieting, maintaining healthy leptin levels through adequate energy intake is crucial. Simply eating enough food might not be enough if hormonal signaling is disrupted; leptin acts as a necessary 'key' to allow immune cells to use energy effectively.

Dose-dependent supplementation with prebiotic fibers (inulin and oligofructose) increases satiety hormones (GLP-1, PYY) and alters gut microbiota (increasing Bacteroidetes, decreasing Firmicutes) in lean and obese states, but does not significantly reduce body fat or body weight in a monogenic obesity model.

Eating prebiotic fibers (like inulin) can improve your gut health and boost satiety hormones, which is beneficial for metabolic regulation. However, in some cases, especially with certain genetic predispositions to obesity, this may not automatically result in weight loss. Focus on the health benefits of fiber rather than expecting it to be a standalone weight-loss solution.

High-protein diets, particularly those relying on animal sources, increase the risk of adverse health outcomes including elevated LDL cholesterol, gout, osteoporosis, and renal stress.

If you choose a high-protein diet, be aware of the potential side effects. Eating too much animal protein can raise bad cholesterol, increase gout risk, and stress the kidneys. People with existing kidney or heart conditions should avoid these diets. Ensure you are getting enough fiber and nutrients from other food groups.

Chronic elevation of reactive oxygen species (ROS) in adipose tissue causes insulin resistance and metabolic dysfunction by impairing insulin signaling and reducing adiponectin secretion.

In obesity, fat cells produce too much oxidative stress (ROS) over time, which blocks insulin from working properly. This isn't about 'bad' stress in small amounts, but chronic overload. Managing weight and reducing fat mass is the primary way to reduce this specific source of oxidative stress and restore insulin sensitivity.

Hypertrophied (enlarged) adipocytes are a significant source of ROS production, primarily via NADPH oxidase (Nox4) and mitochondrial dysfunction, driving local inflammation and metabolic dysfunction.

Large fat cells produce more oxidative stress than small ones. This internal stress contributes to the inflammation and metabolic problems associated with obesity. Reducing fat cell size through weight loss can mitigate this specific source of oxidative stress.

Physiological levels of ROS act as beneficial second messengers that promote insulin sensitivity and adipogenesis, whereas chronic elevation leads to insulin resistance.

Not all oxidative stress is bad. Small amounts of ROS are necessary for normal cellular functions like insulin signaling and fat cell formation. The problem in obesity is the chronic, excessive production that overwhelms these beneficial signals.

Approximately 30% of illicit anabolic-androgenic steroid (AAS) users develop a distinct dependence syndrome characterized by chronic use despite adverse physical and psychosocial effects.

If you are using AAS illicitly, recognize that about 30% of users develop a dependence syndrome. This involves continuing use despite negative health or social consequences, experiencing withdrawal symptoms (fatigue, depression, loss of libido) when stopping, and spending significant time obtaining or using the drug. Standard addiction criteria need adaptation because AAS do not cause acute intoxication. If you are struggling with use, seek help from professionals familiar with AAS culture to address both the physical dependence and the underlying body image concerns.

AAS dependence shares significant neurobiological mechanisms with opioid dependence, including opioid-like withdrawal symptoms and cross-sensitization.

The brain mechanisms underlying AAS dependence overlap with those of opioid addiction. This may explain why AAS users have high rates of opioid abuse and why AAS withdrawal can resemble opioid withdrawal. Treatment strategies for opioid dependence may have relevance for AAS dependence.

Diagnosed diabetes is associated with significantly increased mortality risk from cardiovascular disease, chronic lower respiratory diseases, cerebrovascular disease, influenza/pneumonia, and kidney disease, but not from cancer, accidents, or Alzheimer's disease.

If you have diabetes, your primary focus for longevity should be protecting your heart and kidneys, as these are the conditions most strongly linked to increased mortality risk in diabetic patients. You do not need to assume your risk for cancer or Alzheimer's is higher than that of non-diabetics, though standard preventive care remains important. Prioritize cardiovascular health through blood pressure, lipid, and glucose management.

A high baseline Triglyceride-Glucose (TyG) index, calculated as ln[fasting triglycerides (mg/dL) * FPG (mg/dL) / 2], is a strong independent predictor of incident type 2 diabetes, with individuals in the highest quartile facing a >4-fold higher risk compared to the lowest quartile.

If you are concerned about your risk for type 2 diabetes, ask your doctor to calculate your TyG index using your fasting triglyceride and fasting glucose levels. This simple calculation is a more sensitive early warning system than standard glucose tests alone, especially if you have normal glucose levels but elevated triglycerides. A high result indicates higher insulin resistance and warrants lifestyle interventions to prevent diabetes.

Changing dietary fatty acid composition from saturated to unsaturated (monounsaturated/polyunsaturated) does not significantly improve insulin sensitivity in healthy humans or those with NIDDM in short-term controlled trials.

Switching your fat sources (e.g., from butter to olive oil) is healthy for other reasons, but do not expect it to fix insulin resistance or lower blood sugar quickly. Current evidence suggests this change has little to no immediate effect on how your body handles insulin in healthy people or those with Type 2 Diabetes.

Exercise does not consistently increase skeletal muscle FNDC5 mRNA expression or serum irisin levels in healthy humans, and these markers do not correlate with metabolic health parameters.

Do not rely on measuring or targeting irisin/FNDC5 to gauge exercise effectiveness. Exercise provides significant health benefits regardless of whether these specific markers change, as they do not consistently respond to training in healthy individuals.

Serum irisin levels are not associated with glucose tolerance, insulin resistance (HOMA-IR), or metabolic disturbances in middle-aged men.

Do not use serum irisin levels as a diagnostic tool for metabolic health or glucose tolerance. The absence of a correlation means this marker is not useful for assessing insulin resistance in healthy middle-aged men.

Resistance exercise increases PGC-1α expression but does not consistently increase FNDC5 mRNA or serum irisin, suggesting PGC-1α is not the sole regulator of FNDC5.

Do not assume that increasing PGC-1α through exercise will automatically increase FNDC5 or irisin. The relationship is complex and not consistent across all populations.

Activation of PPARα induces PGC-1α gene expression in brown adipose tissue, thereby contributing to thermogenic activation and the browning of white adipocytes.

This research identifies PPARα as a key regulator that can turn white fat cells into thermogenic brown-like cells by boosting PGC-1α. While this paper uses specific agonists (like Wy14,643) in a lab setting, it suggests that strategies enhancing PPARα activity (such as cold exposure or specific dietary fatty acids known to activate PPARα) may promote fat burning and metabolic health by activating this molecular pathway.

Higher urinary bisphenol A (uBPA) concentrations are associated with increased odds of diabetes, obesity, elevated waist circumference, and hypertension in humans.

Reduce exposure to Bisphenol A (BPA) by avoiding heating food in plastic containers, choosing BPA-free products, and limiting canned food consumption, as higher urinary BPA levels are linked to higher risks of diabetes, obesity, and hypertension.

Acute intranasal insulin administration improves hippocampus-dependent memory and working memory in women, but not in men.

If you are a healthy woman, acute intranasal insulin may help improve your memory, but this effect does not appear to exist for men. This suggests that treatments targeting central insulin signaling for cognitive enhancement may need to account for gender-specific biological responses.

Insulin acts as an anorexigenic signal in the CNS by binding to insulin receptors in the hypothalamus, activating PI3K signaling to inhibit NPY and stimulate POMC, thereby reducing food intake.

Insulin does more than manage blood sugar; it signals your brain that you have enough energy. High insulin levels (common in obesity) can lead to central insulin resistance, blunting this satiety signal. Improving insulin sensitivity through diet and exercise may help restore this natural appetite regulation.

PYY3-36, released from intestinal L-cells after meals, acts as an anorexigenic signal by inhibiting ARC Y2 receptors, leading to increased alpha-MSH and reduced NPY release, thereby reducing appetite.

PYY3-36 is a hormone released by your gut after eating that helps signal fullness to your brain. It works by inhibiting hunger signals (NPY) and promoting satiety signals (alpha-MSH). Diets rich in protein and fiber may naturally boost PYY release, aiding satiety.

Chronic calcium deficiency resulting from inadequate intake or poor absorption causes reduced bone mass and osteoporosis by triggering parathyroid hormone (PTH)-mediated bone resorption.

Ensure you get enough calcium from food sources like dairy or fortified foods, especially if you are postmenopausal or an adolescent, because chronic low intake triggers hormonal processes that break down bone. If you cannot meet intake goals, consider calcium-fortified foods or supplements, but be aware that absorption varies and may not fully prevent bone loss in all groups.